Avoid common mistakes on your manuscript.
Correction to: European Journal of Nuclear Medicine and Molecular Imaging
The authors regret that the text captured in bold font style below that appears in the original article should have been deleted.
“Preliminary results from the first clinical assessments of ZED8 have been presented [25], with further evaluation in multiple solid tumor indications underway (Nature Medicine manuscript NMEDA119285A provisionally accepted pending final revision)”.
The original article can be found at https://doi.org/10.1007/s00259-022-05968-6.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Erratum
Rights and permissions
About this article
Cite this article
Ogasawara, A., Kiefer, J.R., Gill, H. et al. Correction to: Preclinical development of ZED8, an 89Zr immuno‑PET reagent for monitoring tumor CD8 status in patients undergoing cancer immunotherapy. Eur J Nucl Med Mol Imaging 50, 631 (2023). https://doi.org/10.1007/s00259-022-06050-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-022-06050-x